Gam Holding Ag Agios Pharmaceuticals, Inc. Transaction History

Gam Holding Ag

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 09, 2021	SELL	$52.06 - $61.27 $548,035 - $644,989	-10,527 Closed	0 $0
Q1 2021 May 10, 2021	BUY	$44.23 - $57.5 $465,609 - $605,302	10,527 New	10,527 $544,000
Q4 2020 Feb 10, 2021	SELL	$33.21 - $46.54 $717,336 - $1.01 Million	-21,600 Closed	0 $0
Q4 2018 Feb 08, 2019	SELL	$42.73 - $76.53 $111,097 - $198,978	-2,600 Reduced 10.74%	21,600 $996,000
Q4 2017 Feb 14, 2018	BUY	$52.12 - $72.33 $1.26 Million - $1.75 Million	24,200 New	24,200 $1.38 Million
Q3 2017 Nov 14, 2017	SELL	$54.89 - $67.12 $548,900 - $671,200	-10,000 Closed	0 $0
Q2 2017 Aug 07, 2017	BUY	N/A	10,000	10,000 $515,000

243

58.3M

431K

309K

Ticker AGIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 54,818,000
Market Cap $1.82B
Description
Agios Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of medicines in the field of cellular metabolism and adjacent areas of biology. The company offers PYRUKYND (mitapivat) an activator of both wild-type and a variety of mutant pyruvate kinase, PK, enzymes for the treatment of hemolytic anemias; and ...

Get notified when there are updates to the investment portfolio of Gam Holding Ag, based on Form 13F filings with the SEC.

Stay updated on Gam Holding Ag with notifications on news.